25 June 2020>: Database Analysis
Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study
Tian Lan 1ABCDEF** , Yunyan Lu 2BCD* , Hua Luo 1CD , Junling He 1BE , Jiawei He 1CF , Zujian Hu 1EF , Haibin Xu 1A*DOI: 10.12659/MSM.923630
Med Sci Monit 2020; 26:e923630
Table 4 Patient baseline characteristics after PSM.
Characteristic | Divorced (%) | Married (%) | P value | Single (%) | Married (%) | P value | Widowed (%) | Married (%) | P value |
---|---|---|---|---|---|---|---|---|---|
22754 | 22754 | 19148 | 19148 | 19148 | 19148 | ||||
Age | |||||||||
18–49 | 4653 (20.4) | 4734 (20.8) | 0.744 | 440 (2.3) | 440 (2.3) | 0.958 | 440 (2.3) | 440 (2.3) | 0.958 |
50–59 | 6625 (29.1) | 6642 (29.2) | 1718 (9.0) | 1728 (9.0) | 1718 (9.0) | 1728 (9.0) | |||
60–69 | 7093 (31.2) | 7093 (31.2) | 5265 (27.5) | 5251 (27.4) | 5265 (27.5) | 5251 (27.4) | |||
70–79 | 3425 (15.1) | 3335 (14.7) | 7597 (39.7) | 7656 (40.0) | 7597 (39.7) | 7656 (40.0) | |||
≥80 | 958 (4.2) | 950 (4.2) | 4128 (21.6) | 4073 (21.3) | 4128 (21.6) | 4073 (21.3) | |||
Race | |||||||||
White | 17685 (77.7) | 17605 (77.4) | 0.826 | 15575 (81.3) | 15434 (80.6) | 0.084 | 15575 (81.3) | 15434 (80.6) | 0.084 |
Black | 3530 (15.5) | 3582 (15.7) | 1957 (10.2) | 2081 (10.9) | 1957 (10.2) | 2081 (10.9) | |||
API | 1380 (6.1) | 1410 (6.2) | 1492 (7.8) | 1529 (8.0) | 1492 (7.8) | 1529 (8.0) | |||
AI | 159 (0.7) | 157 (0.7) | 124 (0.6) | 104 (0.5) | 124 (0.6) | 104 (0.5) | |||
Gender | |||||||||
Male | 113 (0.5) | 112 (0.5) | 1.000 | 83 (0.4) | 74 (0.4) | 0.522 | 83 (0.4) | 74 (0.4) | 0.522 |
Female | 22641 (99.5) | 22642 (99.5) | 19065 (99.6) | 19074 (99.6) | 19065 (99.6) | 19074 (99.6) | |||
Median household income | |||||||||
Quartile 1 | 6606 (29.0) | 6592 (29.0) | 0.989 | 5905 (30.8) | 5887 (30.7) | 0.195 | 5905 (30.8) | 5887 (30.7) | 0.195 |
Quartile 2 | 5534 (24.3) | 5512 (24.2) | 4628 (24.2) | 4590 (24.0) | 4628 (24.2) | 4590 (24.0) | |||
Quartile 3 | 5623 (24.7) | 5638 (24.8) | 4493 (23.5) | 4385 (22.9) | 4493 (23.5) | 4385 (22.9) | |||
Quartile 4 | 4991 (21.9) | 5012 (22.0) | 4122 (21.5) | 4286 (22.4) | 4122 (21.5) | 4286 (22.4) | |||
Insurance | |||||||||
Uninsured | 500 (2.2) | 501 (2.2) | 1.000 | 180 (0.9) | 185 (1.0) | 0.833 | 180 (0.9) | 185 (1.0) | 0.833 |
Insured | 22254 (97.8) | 22253 (97.8) | 18968 (99.1) | 18963 (99.0) | 18968 (99.1) | 18963 (99.0) | |||
Grade | |||||||||
I | 4634 (20.4) | 4602 (20.2) | 0.917 | 4350 (22.7) | 4300 (22.5) | 0.144 | 4350 (22.7) | 4300 (22.5) | 0.144 |
II | 9265 (40.7) | 9264 (40.7) | 8514 (44.5) | 8383 (43.8) | 8514 (44.5) | 8383 (43.8) | |||
III | 8855 (38.9) | 8888 (39.1) | 6284 (32.8) | 6465 (33.8) | 6284 (32.8) | 6465 (33.8) | |||
Stage | |||||||||
I | 11345 (49.9) | 11360 (49.9) | 0.973 | 10544 (55.1) | 10561 (55.2) | 0.944 | 10544 (55.1) | 10561 (55.2) | 0.944 |
II | 7853 (34.5) | 7821 (34.4) | 6021 (31.4) | 5978 (31.2) | 6021 (31.4) | 5978 (31.2) | |||
III | 2634 (11.6) | 2659 (11.7) | 1830 (9.6) | 1858 (9.7) | 1830 (9.6) | 1858 (9.7) | |||
IV | 922 (4.1) | 914 (4.0) | 753 (3.9) | 751 (3.9) | 753 (3.9) | 751 (3.9) | |||
Subtype | |||||||||
HR−/HER2− (triple negative) | 3079 (13.5) | 3111 (13.7) | 0.871 | 2177 (11.4) | 2256 (11.8) | 0.151 | 2177 (11.4) | 2256 (11.8) | 0.151 |
HR−/HER2+ (HER2 enriched) | 1214 (5.3) | 1178 (5.2) | 902 (4.7) | 925 (4.8) | 902 (4.7) | 925 (4.8) | |||
HR+/HER2− (Luminal A) | 15769 (69.3) | 15771 (69.3) | 14259 (74.5) | 14065 (73.5) | 14259 (74.5) | 14065 (73.5) | |||
HR+/HER2+ (Luminal B) | 2692 (11.8) | 2694 (11.8) | 1810 (9.5) | 1902 (9.9) | 1810 (9.5) | 1902 (9.9) | |||
Surgery | |||||||||
No surgery | 1303 (5.7) | 1294 (5.7) | 0.983 | 1227 (6.4) | 1186 (6.2) | 0.197 | 1227 (6.4) | 1186 (6.2) | 0.197 |
BCS | 12814 (56.3) | 12815 (56.3) | 11428 (59.7) | 11598 (60.6) | 11428 (59.7) | 11598 (60.6) | |||
Mastectomy | 8637 (38.0) | 8645 (38.0) | 6493 (33.9) | 6364 (33.2) | 6493 (33.9) | 6364 (33.2) | |||
Radiation | |||||||||
None/unknown | 10237 (45.0) | 10282 (45.2) | 0.678 | 9507 (49.7) | 9593 (50.1) | 0.385 | 9507 (49.7) | 9593 (50.1) | 0.385 |
Yes | 12517 (55.0) | 12472 (54.8) | 9641 (50.3) | 9555 (49.9) | 9641 (50.3) | 9555 (49.9) | |||
Chemotherapy | |||||||||
No/unknown | 12022 (52.8) | 11956 (52.5) | 0.542 | 13528 (70.6) | 13479 (70.4) | 0.591 | 13528 (70.6) | 13479 (70.4) | 0.591 |
Yes | 10732 (47.2) | 10798 (47.5) | 5620 (29.4) | 5669 (29.6) | 5620 (29.4) | 5669 (29.6) | |||
PSM – propensity score matching. |